What is Oral Rehydration Salts?
Oral rehydration salts are a formulation of sodium chloride, glucose, anhydrous, potassium chloride, trisodium citrate and dehydrate. It is recommended to cure dehydration or loss of water and dissolved salts from the body, most probably occurring, as a result of diarrhea. It is available in form of powder, tablet, and liquid, and sold with a different brand name across globe.
Global Oral Rehydration Salts Market Outlook
Globally, there are nearly 1.7 billion cases of the diarrhoeal disease annually, of which an estimated 760,000 children die annually of the disease. From the past three decades, WHO and UNICEF are recommending the use of a new ORS formulation to prevent or treat dehydration from diarrhea irrespective of the cause or age group affected. The increase in cases of acute diarrhea and the growing population of children under 5 years is fuelling the demand for oral rehydration salts. ORS demand is estimated by the national program, based on epidemiological statistics. UNICEF is supporting governments to scale-up the use of ORS and zinc by sourcing and promoting quality co-packaged ORS and zinc in order to facilitate access in countries requiring a secure and stable program supply.
The market is facing the number of challenges, ORS quantity produced with a 20.5g/1 litre sachet considered too much and a lot is wasted, suppliers consider ORS to be of limited monetary value as they are low-priced and low-profit margin products. To uplift, the demand of ORS, UNICEF took several strategic steps. Introduced flavoured ORS into UNICEF's supply catalogue, availability of 10.2g/0.5 litre sachet and ORS/zinc user-friendly co-packaging developed in accordance with WHO treatment guidelines.
The market is facing a number of challenges, ORS quantity produced with a 20.5g/1 litre sachet considered too much and a lot is wasted, Suppliers consider ORS to be of limited monetary value as they are low-priced and low-profit margin products. Recently. WHO and UNICEF have formulated ORS new formula with improved effectiveness of reduced osmolarity ORS solution, especially for children with acute, non-cholera diarrhea, WHO and UNICEF is now recommending the manufacturer to use and manufacture ORS with a new formula in place of the previously recommended ORS solution. The new formula is composed of reduced osmolarity.

Global Oral Rehydration Salts Market Competitive Landscape
The "Global Oral Rehydration Salts Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Halewood Laboratories Pvt. Ltd., Healthy Life Pharma Private Limited., ALTAR SRI LABS PVT.LTD., Cosmos Limited, Daystar International Group Ltd., KBI Kunststoffbeutel Produktions GmbH & Co. KG, Industrias Quimicas De Centro America, Al Inayah Medical & Health Food, Abbott Laboratories Ltd. and Cera Products, Inc. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1. INTRODUCTION OF GLOBAL ORAL REHYDRATION SALTS MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL ORAL REHYDRATION SALTS MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL ORAL REHYDRATION SALTS MARKET, BY FORM
5.1. Overview
5.2. Powder
5.3. Tablet
5.4. Liquid

6. GLOBAL ORAL REHYDRATION SALTS MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.2. Pharmacies
6.3. Shops
6.4. Health Centres
6.5. Other

7. GLOBAL ORAL REHYDRATION SALTS MARKET, BY APPLICATION
7.1. Overview
7.2. Children
7.3. Infant
7.4. Adult

8. GLOBAL ORAL REHYDRATION SALTS MARKET, BY GEOGRAPHY
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Rest of Europe
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia Pacific
8.5. Rest of the World
9. GLOBAL ORAL REHYDRATION SALTS MARKET COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Company Market Ranking
9.3. Key Development Strategies
10. COMPANY PROFILES
10.1. Halewood Laboratories Pvt. Ltd.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2. Healthy Life Pharma Private Limited.
10.2.1. Overview
10.2.2. Financial Performance
10.2.3. Product Outlook
10.2.4. Key Developments
10.3. ALTAR SRI LABS PVT.LTD.
10.3.1. Overview
10.3.2. Financial Performance
10.3.3. Product Outlook
10.3.4. Key Developments
10.4. Cosmos Limited
10.4.1. Overview
10.4.2. Financial Performance
10.4.3. Product Outlook
10.4.4. Key Developments
10.5. Daystar International Group Ltd.
10.5.1. Overview
10.5.2. Financial Performance
10.5.3. Product Outlook
10.5.4. Key Developments
10.6. KBI Kunststoffbeutel Produktions GmbH & Co. KG.
10.6.1. Overview
10.6.2. Financial Performance
10.6.3. Product Outlook
10.6.4. Key Developments
10.7. Industrias Quimicas De Centro America.
10.7.1. Overview
10.7.2. Financial Performance
10.7.3. Product Outlook
10.7.4. Key Developments
10.8. Abbott Laboratories Ltd.
10.8.1. Overview
10.8.2. Financial Performance
10.8.3. Product Outlook
10.8.4. Key Developments
10.9. Al Inayah Medical & Health Food
10.9.1. Overview
10.9.2. Financial Performance
10.9.3. Product Outlook
10.9.4. Key Developments
10.10. Cera Products, Inc.
10.10.1. Overview
10.10.2. Financial Performance
10.10.3. Product Outlook
10.10.4. Key Developments

11. Appendix
11.1. Related Reports

Personalized Oral Learning Platform Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Personalized Oral Learning Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness substantial growth from 2024 to 2034, driven by the rising prevalence of IPF, advancements in drug development, and an increasing focus on early diagnosis and treatment. The market is proj...

Europe Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness significant growth between 2024 and 2034, driven by the increasing prevalence of IPF, advancements in drug development, and improved diagnostic methods. The market is projected to reach USD XX.X...

North America Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Idiopathic Pulmonary Fibrosis (IPF) Market is projected to experience robust growth from 2024 to 2034, driven by advancements in therapeutic options, increasing prevalence of IPF, and a growing emphasis on early diagnosis and treatment. The market size ...

Global Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Idiopathic Pulmonary Fibrosis (IPF) Market is poised to experience significant growth between 2024 and 2034, driven by advancements in drug development, increasing prevalence of IPF, and heightened awareness about the disease. Valued at USD XX.XX billion in 20...

Compound Pholcodine Oral Solution Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Compound Pholcodine Oral Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...

Bismuth Potassium Citrate Oral Solution Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Bismuth Potassium Citrate Oral Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...

Medical Oral Rehydration Solution Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Medical Oral Rehydration Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...

Oral Solid Dosage Formulation Development Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Oral Solid Dosage Formulation Development Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competit...

United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type (GnRH Antagonists, Progesterone, GnRH Agonists and Others), By Route of Administration (Oral and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "United States Endometriosis and Uterine Fibroids Market (2024 Edition)" which provides a complete analysis of the United States Endometriosis and Uterine Fibroids industry in terms of market segmentation By Drug Ty...